Glyburide Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Glyburide Market covers analysis By Therapeutic Effect (Diabetes Mellitus Type-II, Blood Sugar, Others); Application (Pediatric Patents, Geriatric Patients) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00020040
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Glyburide Market Insights and Growth by 2031

Buy Now

MARKET INTRODUCTION

Glyburide is also known as glibenclamide is a drug belong to sulfonyl urea category and is used to treat type 2 diabetes mellitus. Glyburide helps in lowering blood glucose level by stimulating pancreas to produce more insulin. Glyburide is suggested to take together with exercise and diet and is given by oral route. Common side effects of glyburide are, heartburn, nausea, angioedema etc.

MARKET DYNAMICS

The key market drivers for Glyburide Market are, rising prevalence of type 2 diabetes mellitus across the globe, growing geriatric and obese population, increasing prevalence of genetic disorders. Additionally, high R&D investments by drug companies to develop more effective therapies for management of diabetes is expected to drive market growth during forecast period. Moreover, presence of fixed dose combinations, combination drugs with glyburide is also expected to boost market growth during forecast period. Whereas, some of the side effects associated with drug is expected to hinder market during forecast period.

MARKET SCOPE

The "Glyburide Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glyburide market with detailed market segmentation by therapeutic effect and application. The Glyburide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Glyburide Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Glyburide Market is segmented on the basis of therapeutic effect and application. On the basis of therapeutic effect the market is segmented as, diabetes mellitus type 2, blood sugar, others. And on the basis of application the market is segmented as, pediatric patients, geriatric patients.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glyburide Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glyburide Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Glyburide Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glyburide Market in these regions.

World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glyburide Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glyburide Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Glyburide Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glyburide Market in these regions.

MARKET PLAYERS

The report covers key developments in the Glyburide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glyburide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Glyburide market in the global market. Below mentioned is the list of few companies engaged in the Glyburide Market.

The report also includes the profiles of key players in Glyburide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Pfizer
  •   Sandoz
  •   Novartis
  •   Bristol Myers Squibb
  •   Sigma-Aldrich
  •   Hikma Pharmaceuticals
  •   Amneal Pharmaceuticals
  •   Sanofi
  •   Cadila Pharmaceuticals
  •   Apotex Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glyburide Market - By Therapeutic Effect
1.3.2 Glyburide Market - By Application
1.3.3 Glyburide Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GLYBURIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GLYBURIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GLYBURIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. GLYBURIDE - GLOBAL MARKET OVERVIEW
6.2. GLYBURIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GLYBURIDE MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC EFFECT
7.1. OVERVIEW
7.2. THERAPEUTIC EFFECT MARKET FORECASTS AND ANALYSIS
7.3. DIABETES MELLITUS TYPE-II
7.3.1. Overview
7.3.2. Diabetes Mellitus Type-II Market Forecast and Analysis
7.4. BLOOD SUGAR
7.4.1. Overview
7.4.2. Blood Sugar Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. GLYBURIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC PATENTS
8.3.1. Overview
8.3.2. Pediatric Patents Market Forecast and Analysis
8.4. GERIATRIC PATIENTS
8.4.1. Overview
8.4.2. Geriatric Patients Market Forecast and Analysis

9. GLYBURIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Glyburide Market Overview
9.1.2 North America Glyburide Market Forecasts and Analysis
9.1.3 North America Glyburide Market Forecasts and Analysis - By Therapeutic Effect
9.1.4 North America Glyburide Market Forecasts and Analysis - By Application
9.1.5 North America Glyburide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Glyburide Market
9.1.5.1.1 United States Glyburide Market by Therapeutic Effect
9.1.5.1.2 United States Glyburide Market by Application
9.1.5.2 Canada Glyburide Market
9.1.5.2.1 Canada Glyburide Market by Therapeutic Effect
9.1.5.2.2 Canada Glyburide Market by Application
9.1.5.3 Mexico Glyburide Market
9.1.5.3.1 Mexico Glyburide Market by Therapeutic Effect
9.1.5.3.2 Mexico Glyburide Market by Application
9.2. EUROPE
9.2.1 Europe Glyburide Market Overview
9.2.2 Europe Glyburide Market Forecasts and Analysis
9.2.3 Europe Glyburide Market Forecasts and Analysis - By Therapeutic Effect
9.2.4 Europe Glyburide Market Forecasts and Analysis - By Application
9.2.5 Europe Glyburide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Glyburide Market
9.2.5.1.1 Germany Glyburide Market by Therapeutic Effect
9.2.5.1.2 Germany Glyburide Market by Application
9.2.5.2 France Glyburide Market
9.2.5.2.1 France Glyburide Market by Therapeutic Effect
9.2.5.2.2 France Glyburide Market by Application
9.2.5.3 Italy Glyburide Market
9.2.5.3.1 Italy Glyburide Market by Therapeutic Effect
9.2.5.3.2 Italy Glyburide Market by Application
9.2.5.4 Spain Glyburide Market
9.2.5.4.1 Spain Glyburide Market by Therapeutic Effect
9.2.5.4.2 Spain Glyburide Market by Application
9.2.5.5 United Kingdom Glyburide Market
9.2.5.5.1 United Kingdom Glyburide Market by Therapeutic Effect
9.2.5.5.2 United Kingdom Glyburide Market by Application
9.2.5.6 Rest of Europe Glyburide Market
9.2.5.6.1 Rest of Europe Glyburide Market by Therapeutic Effect
9.2.5.6.2 Rest of Europe Glyburide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Glyburide Market Overview
9.3.2 Asia-Pacific Glyburide Market Forecasts and Analysis
9.3.3 Asia-Pacific Glyburide Market Forecasts and Analysis - By Therapeutic Effect
9.3.4 Asia-Pacific Glyburide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Glyburide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Glyburide Market
9.3.5.1.1 Australia Glyburide Market by Therapeutic Effect
9.3.5.1.2 Australia Glyburide Market by Application
9.3.5.2 China Glyburide Market
9.3.5.2.1 China Glyburide Market by Therapeutic Effect
9.3.5.2.2 China Glyburide Market by Application
9.3.5.3 India Glyburide Market
9.3.5.3.1 India Glyburide Market by Therapeutic Effect
9.3.5.3.2 India Glyburide Market by Application
9.3.5.4 Japan Glyburide Market
9.3.5.4.1 Japan Glyburide Market by Therapeutic Effect
9.3.5.4.2 Japan Glyburide Market by Application
9.3.5.5 South Korea Glyburide Market
9.3.5.5.1 South Korea Glyburide Market by Therapeutic Effect
9.3.5.5.2 South Korea Glyburide Market by Application
9.3.5.6 Rest of Asia-Pacific Glyburide Market
9.3.5.6.1 Rest of Asia-Pacific Glyburide Market by Therapeutic Effect
9.3.5.6.2 Rest of Asia-Pacific Glyburide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Glyburide Market Overview
9.4.2 Middle East and Africa Glyburide Market Forecasts and Analysis
9.4.3 Middle East and Africa Glyburide Market Forecasts and Analysis - By Therapeutic Effect
9.4.4 Middle East and Africa Glyburide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Glyburide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Glyburide Market
9.4.5.1.1 South Africa Glyburide Market by Therapeutic Effect
9.4.5.1.2 South Africa Glyburide Market by Application
9.4.5.2 Saudi Arabia Glyburide Market
9.4.5.2.1 Saudi Arabia Glyburide Market by Therapeutic Effect
9.4.5.2.2 Saudi Arabia Glyburide Market by Application
9.4.5.3 U.A.E Glyburide Market
9.4.5.3.1 U.A.E Glyburide Market by Therapeutic Effect
9.4.5.3.2 U.A.E Glyburide Market by Application
9.4.5.4 Rest of Middle East and Africa Glyburide Market
9.4.5.4.1 Rest of Middle East and Africa Glyburide Market by Therapeutic Effect
9.4.5.4.2 Rest of Middle East and Africa Glyburide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Glyburide Market Overview
9.5.2 South and Central America Glyburide Market Forecasts and Analysis
9.5.3 South and Central America Glyburide Market Forecasts and Analysis - By Therapeutic Effect
9.5.4 South and Central America Glyburide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Glyburide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Glyburide Market
9.5.5.1.1 Brazil Glyburide Market by Therapeutic Effect
9.5.5.1.2 Brazil Glyburide Market by Application
9.5.5.2 Argentina Glyburide Market
9.5.5.2.1 Argentina Glyburide Market by Therapeutic Effect
9.5.5.2.2 Argentina Glyburide Market by Application
9.5.5.3 Rest of South and Central America Glyburide Market
9.5.5.3.1 Rest of South and Central America Glyburide Market by Therapeutic Effect
9.5.5.3.2 Rest of South and Central America Glyburide Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. GLYBURIDE MARKET, KEY COMPANY PROFILES
11.1. PFIZER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANDOZ
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS BRISTOL MYERS SQUIBB
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SIGMA-ALDRICH
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HIKMA PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. AMNEAL PHARMACEUTICALS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CADILA PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. APOTEX CORPORATION
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Sandoz
3. Novartis Bristol Myers Squibb
4. Sigma-Aldrich
5. Hikma Pharmaceuticals
6. Amneal Pharmaceuticals
7. Sanofi
8. Cadila Pharmaceuticals
9. Apotex Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..